-
*Takashi Nagayama
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association UCB Japan Co., Ltd.
-
Nobuyuki Baba
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Mitsubishi Pharma Corporation
-
Hirohiko Goto
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Otsuka Pharmaceutical Co., Ltd.
-
Tetsushi Dodo
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Eisai Co., Ltd.
-
Katsuyuki Nishiki
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Schering-Plough K.K.
-
Kazuhiro Shimomura
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Daiichi Pharmaceutical Co., Ltd.
-
Kouji Koike
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Nippon Zoki Pharmaceutical Co., Ltd.
-
Toru Nawa
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Meiji Seika Kaisha, Ltd.
-
Masao Horimoto
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Pfizer Global Research & Development
-
Fumio Sagami
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Eisai Co., Ltd.
